Intellia Therapeutics (NTLA) Other Non-Current Assets (2016 - 2025)
Historic Other Non-Current Assets for Intellia Therapeutics (NTLA) over the last 10 years, with Q3 2025 value amounting to $2.9 million.
- Intellia Therapeutics' Other Non-Current Assets fell 972.14% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 972.14%. This contributed to the annual value of $3.8 million for FY2024, which is 1615.76% down from last year.
- As of Q3 2025, Intellia Therapeutics' Other Non-Current Assets stood at $2.9 million, which was down 972.14% from $3.6 million recorded in Q2 2025.
- Intellia Therapeutics' Other Non-Current Assets' 5-year high stood at $5.2 million during Q3 2021, with a 5-year trough of $2.9 million in Q3 2025.
- Its 4-year average for Other Non-Current Assets is $3.9 million, with a median of $3.8 million in 2024.
- In the last 5 years, Intellia Therapeutics' Other Non-Current Assets soared by 7722.28% in 2021 and then crashed by 2489.32% in 2025.
- Quarter analysis of 4 years shows Intellia Therapeutics' Other Non-Current Assets stood at $5.2 million in 2021, then dropped by 12.53% to $4.5 million in 2023, then decreased by 16.16% to $3.8 million in 2024, then decreased by 23.02% to $2.9 million in 2025.
- Its Other Non-Current Assets stands at $2.9 million for Q3 2025, versus $3.6 million for Q2 2025 and $3.0 million for Q1 2025.